Chong Kun Dang Pharmaceutical Corp
KRX:185750
Chong Kun Dang Pharmaceutical Corp
Revenue
Chong Kun Dang Pharmaceutical Corp
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Chong Kun Dang Pharmaceutical Corp
KRX:185750
|
Revenue
₩1.6T
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Revenue
₩2.1T
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Revenue
₩547.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Revenue
₩1.5T
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Revenue
₩210.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Revenue
₩477.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
22%
|
CAGR 10-Years
22%
|
|
Chong Kun Dang Pharmaceutical Corp
Glance View
Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-12-06. The firm is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The firm sells products in domestic and overseas markets.
See Also
What is Chong Kun Dang Pharmaceutical Corp's Revenue?
Revenue
1.6T
KRW
Based on the financial report for Dec 31, 2024, Chong Kun Dang Pharmaceutical Corp's Revenue amounts to 1.6T KRW.
What is Chong Kun Dang Pharmaceutical Corp's Revenue growth rate?
Revenue CAGR 5Y
8%
Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for Chong Kun Dang Pharmaceutical Corp have been 6% over the past three years , 8% over the past five years .
You don't have any saved screeners yet